NCT07416188 2026-03-18
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Dana-Farber Cancer Institute
Centre Hospitalier Universitaire de la Réunion
Neonc Technologies, Inc.
Catalysis SL